# DEFLAZACORT
> **ANDA217123** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2024-02-09
## Drug
- **FDA Application Number:** ANDA217123
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFLAZACORT
- **Generic name:** DEFLAZACORT
- **Active ingredients:** DEFLAZACORT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2024-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217123)
---
*MORVS · CC0 1.0*